Background
Results
ASSP2 expression is lower in cancerous tissues and predicts a poor prognosis
No. of patients | ASPP2 expression |
p-value | ||
---|---|---|---|---|
Low expression n=47 | High expression n=18 | |||
Age (years) Mean±SD | 65 | 54.8+13.2 | 59.1+11.2 | 0.362 |
Gender | ||||
Male | 44 | 35 | 9 | 0.061 |
Female | 21 | 12 | 9 | |
Histopathological grade | ||||
G1 | 18 | 17 | 1 | 0.013 |
G2,3 | 47 | 30 | 17 | |
Depth of invasion | ||||
T1, 2 | 41 | 27 | 14 | 0.133 |
T3, 4 | 24 | 20 | 4 | |
Lymph node metastasis | ||||
Negative | 33 | 23 | 10 | 0.639 |
Positive | 32 | 24 | 8 | |
Pathologic stage | ||||
I, II | 59 | 44 | 15 | 0.203 |
III, IV | 6 | 3 | 3 |
ASPP2 inhibit proliferation of pancreatic cancer cell
ASPP2 negatively regulate basal autophagy in pancreatic cancer cell lines
ASPP2 regulate autophagy through AMPK-mTOR pathways
ASPP2 can facilitate gemcitabine induced cell apoptosis through regulation of autophagy in vitro and in vivo
Discussion
Conclusions
Methods
Patients and samples
Cell culture and reagent
RT-qPCR assay
Sequence of primers for real-time PCR
Primer | Sequence (5′ to 3’) |
---|---|
ASPP2 forward primer | 5’-TAAGCAATGGGAAACTTGTGG-3’ |
ASPP2 reverse primer | 5’-CATCCGAGGCATAGTAGACGA-3’ |
18 s forward primer | 5’-CGGCTACCACATCCAAGGAA-3’ |
18 s reverse primer | 5’-GCTGGAATTACCGCGGCT-3’ |
ShRNA Interference
Gene | Forward | Reverse |
---|---|---|
ASPP2#1 | 5’-CACCGCAGAATGCCAAGCTACAACACGAATGTTGTAGCTTGGCATTCTGC -3’ | 5’-AAAAGCAGAATGCCAAGCTACAACATTCGTGTTGTAGCTTGGCATTCTGC -3’ |
ASPP2#2 | 5’-CACCGCTGCAGTAGGTCCCTATATCCGAAGATATAGGGACCTACTGCAGC -3’ | 5’-AAAAGCTGCAGTAGGTCCCTATATCTTCGGATATAGGGACCTACTGCAGC -3’ |
ASPP2#3 | 5’-CACCGCGTCCGTTCTCAATGTTTGACGAATCAAACATTGAGAACGGACGC -3’ | 5’-AAAAGCGTCCGTTCTCAATGTTTGATTCGTCAAACATTGAGAACGGACGC -3’ |
AMPK#1 | 5’-CACCGCTTGATGCACACATGAATGCCGAAGCATTCATGTGTGCATCAAGC -3’ | 5’-AAAAGCTTGATGCACACATGAATGCTTCGGCATTCATGTGTGCATCAAGC -3’ |
AMPK#2 | 5’-CACCGCAGGCCCAGAGGTAGATATACGAATATATCTACCTCTGGGCCTGC -3’ | 5’-AAAAGCAGGCCCAGAGGTAGATATATTCGTATATCTACCTCTGGGCCTGC -3’ |
AMPK#3 | 5’-CACCGCAGAAGTATGTAGAGCAATCCGAAGATTGCTCTACATACTTCTGC -3’ | 5’-AAAAGCAGAAGTATGTAGAGCAATCTTCGGATTGCTCTACATACTTCTGC -3’ |